Immediate Impact
2 from Science/Nature 53 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
Works of Jérôme Deval being referenced
Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
2021
Innovation and trends in the development and approval of antiviral medicines: 1987–2017 and beyond
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jérôme Deval | 35 | 228 | 138 | 115 | 12 | 387 | |
| Adam Sherwat | 48 | 169 | 148 | 160 | 11 | 386 | |
| Ornjira Aruksakunwong | 12 | 119 | 220 | 146 | 17 | 374 | |
| Brenda I. Hernández-Santiago | 119 | 304 | 142 | 166 | 16 | 446 | |
| Adele Boccuto | 15 | 231 | 84 | 66 | 30 | 418 | |
| Karl Frank | 22 | 136 | 112 | 161 | 17 | 357 | |
| Janet L. Paulsen | 21 | 133 | 217 | 37 | 16 | 414 | |
| Joan Zugay-Murphy | 55 | 130 | 200 | 44 | 9 | 360 | |
| A.T. Gres | 39 | 153 | 126 | 63 | 14 | 347 | |
| Surya Sankuratri | 42 | 160 | 136 | 60 | 15 | 432 | |
| Christine Burlein | 105 | 179 | 183 | 96 | 18 | 442 |
All Works
Login with ORCID to disown or claim papers
Loading papers...